M02.32

Clinical Causes: Infection with certain bacteria, commonly transmitted through contaminated food or water, sexual contact, or other means. Genetic predisposition, such as having the HLA-B27 gene, which increases susceptibility. Other environmental factors that may trigger immune responses leading to joint inflammation.

Key Symptoms: Swelling, redness, and warmth around the elbow joint. Pain or tenderness in the elbow, often worsening with movement. Reduced range of motion due to joint stiffness. General symptoms like fever, fatigue, or malaise during acute phases. Possible inflammation in other areas like the eyes or urinary tract.

Diagnosis Path: Diagnosis of Reiter's disease of the elbow involves a combination of medical history, physical examination, and laboratory tests. Physicians often look for evidence of recent infection and check for HLA-B27 gene presence. Imaging tests such as X-rays may reveal joint inflammation or damage, though early stages may not show significant changes. Blood tests can help rule out other types of arthritis or infections, and synovial fluid analysis from the affected elbow can identify infectious agents or inflammation markers.

Treatment Protocols: Managing Reiter's disease of the elbow typically involves a combination of treatments aimed at reducing inflammation and addressing any underlying infection if present. Common approaches include: - Non-steroidal anti-inflammatory drugs (NSAIDs) to relieve pain and swelling. - Corticosteroids, administered orally or directly into the joint, to control severe inflammation. - Physical therapy to maintain joint function and mobility. - Antibiotics if a bacterial infection is identified as the trigger. - Rest and ice application to manage acute symptoms. - Monitoring for and treating any additional complications, such as eye or urinary tract issues. In some cases, disease-modifying antirheumatic drugs (DMARDs) might be prescribed if symptoms persist or worsen.